# A Single Dose Randomized Five-Way Crossover Pharmacokinetics (PK) Study of Tadalafil Semi-Chewable (Gummy) Formulations in Healthy Volunteers

> **NCT04762082** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Seattle Gummy Company** · enrollment: 30 (estimated)

## Conditions studied

- Erectile Dysfunction

## Interventions

- **DRUG:** Tadalafil 10 MG

## Key facts

- **NCT ID:** NCT04762082
- **Lead sponsor:** Seattle Gummy Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-05-01
- **Primary completion:** 2025-08-30
- **Final completion:** 2025-12-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04762082

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04762082, "A Single Dose Randomized Five-Way Crossover Pharmacokinetics (PK) Study of Tadalafil Semi-Chewable (Gummy) Formulations in Healthy Volunteers". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04762082. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*